Hosoya K, Fujimoto D, Morimoto T, Kumagai T, et al. Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study. BMC Cancer 2021;21:346.
PMID: 33794809